GI-Y2 is a GSDMD inhibitor that suppresses macrophage pyroptosis induced by oxidized low-density lipoprotein (ox-LDL). In vivo, GI-Y2 dose-dependently reduces atherosclerotic plaques and decreases lesion size and fibrosis in the aortic root of ApoE-/- mice. GI-Y2 holds potential for research in pyroptosis and cardiovascular diseases, such as atherosclerosis.
Molecular Weight:
386.379
CAS Number:
[1008710-58-4]
Formula:
C18H14N2O6S
Target:
Pyroptosis
* VAT and and shipping costs not included. Errors and price changes excepted
